During the past decade, NeuroTrials Research Inc conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 38 clinical trials were completed, i.e. on average, 58.5% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 28 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NeuroTrials Research Inc" #1 sponsor was "Jazz Pharmaceuticals" with 7 trials, followed by "Cephalon" with 6 trials sponsored, "Philips Respironics" with 5 trials sponsored, "Allergan" with 4 trials sponsored and "Eisai Inc." with 4 trials sponsored. Other sponsors include 65 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NeuroTrials Research Inc" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "PPD" with 2 trials as a collaborator, "Purdue Pharma LP" with 2 trials as a collaborator, "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator and "Cognitive Research Corporation" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "NeuroTrials Research Inc" are "Narcolepsy" (11 trials), "Excessive Daytime Sleepiness" (6 trials), "Idiopathic Hypersomnia" (6 trials), "Obstructive Sleep Apnea" (6 trials) and "Alzheimer's Disease" (5 trials). Many other conditions were trialed in "NeuroTrials Research Inc" in a lesser frequency.

Most popular intervention types in "NeuroTrials Research Inc" are "Drug" (79 trials), "Device" (11 trials), "Other" (7 trials), "Biological" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (47 trials), "placebo" (3 trials), "ABP-450" (2 trials), "ADX-N05" (2 trials) and "AVP-786" (2 trials). Other intervention names were less common.

The vast majority of trials in "NeuroTrials Research Inc" are 95 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "NeuroTrials Research Inc". undefined are not yet recruiting, 9 are recruiting, 3 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 74 completed trials in NeuroTrials Research Inc, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in NeuroTrials Research Inc, 8 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".